GW5074
CAS-Nr.
220904-83-6
Englisch Name:
GW5074
Synonyma:
W5074;GW5074;CS-399;GW5074, >=98%;GW-5074;GW 5074;GW5074 USP/EP/BP;GW 5074;GW-5074;GW5074;GW 5074, 10 mM in DMSO;RAF1 KINASE INHIBITOR I;GW5074, c-Raf1 kinase inhibitor
CBNumber:
CB0130215
Summenformel:
C15H8Br2INO2
Molgewicht:
520.94
MOL-Datei:
220904-83-6.mol
GW5074 Eigenschaften
Siedepunkt:
561.4±50.0 °C(Predicted)
Dichte
2.248±0.06 g/cm3(Predicted)
storage temp.
room temp
L?slichkeit
DMSO: soluble
Aggregatzustand
solid
pka
5.86±0.25(Predicted)
Farbe
yellow to orange-brown
Stabilit?t:
Stable for 2 years from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 1 month.
InChIKey
LMXYVLFTZRPNRV-XCVCLJGOSA-N
CAS Datenbank
220904-83-6
Sicherheit
Risiko- und Sicherheitserkl?rung
Gefahreninformationscode (GHS)
WGK Germany
3
HS Code
2933790090
Bildanzeige (GHS)
Alarmwort
Warnung
Gefahrenhinweise
Code
Gefahrenhinweise
Gefahrenklasse
Abteilung
Alarmwort
Symbol
P-Code
H302
Gesundheitssch?dlich bei Verschlucken.
Akute Toxizit?t oral
Kategorie 4
Warnung
src="/GHS07.jpg" width="20" height="20" />
P264, P270, P301+P312, P330, P501
H315
Verursacht Hautreizungen.
Hautreizung
Kategorie 2
Warnung
src="/GHS07.jpg" width="20" height="20" />
P264, P280, P302+P352, P321,P332+P313, P362
H319
Verursacht schwere Augenreizung.
Schwere Augenreizung
Kategorie 2
Warnung
src="/GHS07.jpg" width="20" height="20" />
P264, P280, P305+P351+P338,P337+P313P
H335
Kann die Atemwege reizen.
Spezifische Zielorgan-Toxizit?t (einmalige Exposition)
Kategorie 3 (Atemwegsreizung)
Warnung
src="/GHS07.jpg" width="20" height="20" />
Sicherheit
P261
Einatmen von Staub vermeiden.
P305+P351+P338
BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach M?glichkeit entfernen. Weiter spülen.
GW5074 Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
GW5074 has been used as a specific inhibitor of cRaf1 in C2 murine skeletal myoblasts, HT-29 colorectal adenocarcinoma cell line and neutrophils.
Biologische Aktivit?t
Potent, selective and cell-permeable c-Raf1 kinase inhibitor (IC 50 = 9 nM). Displays ≥ 100-fold selectivity for raf kinase over CDK1, CDK2, c-src, ERK2, MEK, p38, Tie2, VEGFR2 and c-fm.
Biochem/physiol Actions
GW5074 is a cRaf1 kinase inhibitor, which is placed immediately downstream of Ras in the Motogen activated protein kinase (MAPK) signaling pathway. It elicits protection in GW5074 prevents degeneration in Huntington′s disease and also have therapeutic potential in treating neurodegenerative disorders. GW5074 in combination with anti-inflammatory drug, dexamethasone, attenuates sidestream smoke-induced airway inflammation.
GW5074 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
GW5074 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 160)Lieferanten
China 129
Germany 1
India 1
Japan 1
Switzerland 2
United Kingdom 2
United States 24
Global 160
RAF1 KINASE INHIBITOR I
(3Z)-3-[(3,5-DIBROMO-4-HYDROXYPHENYL)METHYLIDENE]-5-IODO-1H-INDOL-2-ONE
5-IODO-3-[(3,5-DIBROMO-4-HYDROXYPHENYL)METHYLENE]-2-INDOLINONE
3-(3,5-DIBROMO-4-HYDROXY-BENZYLIDENE)-5-IODO-1,3-DIHYDRO-INDOL-2-ONE
3-(3,5-DIBROMO-4-HYDROXYBENZYLIDINE)-5-IODO-1,3-DIHYDRO-INDOL-2-ONE
GW5074
2H-Indol-2-one, 3-[(3,5-dibromo-4-hydroxyphenyl)methylene]-1,3-dihydro-5-iodo-
3-(3,5-dibromo-4-hydroxybenzyliden)-5-iodo-1,3-dihydroindol-2-one
GW5074, >=98%
(Z)-3-(3,5-dibromo-4-hydroxybenzylidene)-5-iodoindolin-2-one
GW-5074;GW 5074
Raf1 Kinase Inhibitor I - CAS 220904-83-6 - Calbiochem
GW 5074;GW-5074;GW5074
CS-399
W5074
GW5074 USP/EP/BP
3-(3,5-Dibromo-4-hydroxybenzylidene)-5-iodo-2,3-dihydro-1H-indol-2-one
3-(3,5-dibromo-4-hydroxybenzylidene)-5-iodoindolin-2-one
(3E)-3-[(3,5-dibromo-4-hydroxyphenyl)methylidene]-5-iodo-1H-indol-2-one
GW5074, c-Raf1 kinase inhibitor
GW 5074, 10 mM in DMSO
220904-83-6
20904-83-6
C15H8Br2INO2
BioChemical
Cell Signaling and Neuroscience
Cell Biology
Kinase/Phosphatase Biology
Raf
Serine/Threonine Kinase Inhibitors
MAPK
Inhibitors